Mind Medicine (MindMed) Statistics
Total Valuation
MNMD has a market cap or net worth of $417.54 million. The enterprise value is $170.55 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, before market open.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MNMD has 75.37 million shares outstanding. The number of shares has increased by 79.94% in one year.
Current Share Class | 75.37M |
Shares Outstanding | 75.37M |
Shares Change (YoY) | +79.94% |
Shares Change (QoQ) | +4.60% |
Owned by Insiders (%) | 1.15% |
Owned by Institutions (%) | 49.62% |
Float | 70.19M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.82 |
P/TBV Ratio | 1.91 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.25, with a Debt / Equity ratio of 0.09.
Current Ratio | 7.25 |
Quick Ratio | 7.05 |
Debt / Equity | 0.09 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -45.52 |
Financial Efficiency
Return on equity (ROE) is -68.01% and return on invested capital (ROIC) is -36.53%.
Return on Equity (ROE) | -68.01% |
Return on Assets (ROA) | -30.44% |
Return on Invested Capital (ROIC) | -36.53% |
Return on Capital Employed (ROCE) | -39.47% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.47M |
Employee Count | 74 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.06% in the last 52 weeks. The beta is 2.40, so MNMD's price volatility has been higher than the market average.
Beta (5Y) | 2.40 |
52-Week Price Change | -41.06% |
50-Day Moving Average | 7.15 |
200-Day Moving Average | 7.01 |
Relative Strength Index (RSI) | 32.02 |
Average Volume (20 Days) | 1,259,653 |
Short Selling Information
The latest short interest is 11.37 million, so 15.09% of the outstanding shares have been sold short.
Short Interest | 11.37M |
Short Previous Month | 11.81M |
Short % of Shares Out | 15.09% |
Short % of Float | 16.20% |
Short Ratio (days to cover) | 4.92 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -103.92M |
Pretax Income | -125.32M |
Net Income | -108.68M |
EBITDA | -103.89M |
EBIT | -103.92M |
Earnings Per Share (EPS) | -$1.54 |
Full Income Statement Balance Sheet
The company has $273.74 million in cash and $21.85 million in debt, giving a net cash position of $251.89 million or $3.34 per share.
Cash & Cash Equivalents | 273.74M |
Total Debt | 21.85M |
Net Cash | 251.89M |
Net Cash Per Share | $3.34 |
Equity (Book Value) | 241.45M |
Book Value Per Share | 3.21 |
Working Capital | 242.77M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -79.13M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -79.94% |
Shareholder Yield | -79.94% |
Earnings Yield | -25.73% |
FCF Yield | n/a |
Analyst Forecast
The average price target for MNMD is $25.75, which is 364.80% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $25.75 |
Price Target Difference | 364.80% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 0.0666667:1.
Last Split Date | Aug 29, 2022 |
Split Type | Reverse |
Split Ratio | 0.0666667:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |